News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
18,622 Results
Type
Article (834)
Company Profile (1)
Press Release (17787)
Section
Business (3803)
Career Advice (11)
Deals (819)
Drug Delivery (5)
Drug Development (2092)
FDA (491)
Job Trends (254)
News (7259)
Policy (627)
Tag
Academia (49)
Allergies (3)
Alliances (1265)
ALS (2)
Alzheimer's disease (42)
Antibody-drug conjugate (ADC) (2)
Approvals (522)
Artificial intelligence (10)
Autoimmune disease (1)
Automation (1)
Bankruptcy (5)
Best Places to Work (203)
Biosimilars (2)
Bladder cancer (5)
Brain cancer (5)
Breast cancer (36)
Cancer (166)
Cardiovascular disease (30)
Career advice (10)
CAR-T (4)
Cell therapy (22)
Cervical cancer (1)
Clinical research (1897)
Collaboration (53)
Compensation (6)
COVID-19 (93)
CRISPR (3)
C-suite (22)
Cystic fibrosis (8)
Data (281)
Depression (2)
Dermatology (1)
Diabetes (15)
Diagnostics (255)
Digital health (1)
Drug discovery (5)
Drug pricing (1)
Duchenne muscular dystrophy (23)
Earnings (1567)
Editorial (2)
Events (2263)
Executive appointments (16)
FDA (598)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (41)
Gene editing (8)
Generative AI (1)
Gene therapy (42)
GLP-1 (22)
Government (70)
Guidances (19)
Healthcare (350)
IgA nephropathy (1)
Immunology and inflammation (4)
Indications (4)
Infectious disease (100)
Inflammatory bowel disease (7)
Influenza (1)
Intellectual property (6)
IPO (217)
Job creations (60)
Job search strategy (10)
JPM (1)
Layoffs (10)
Legal (101)
Liver cancer (3)
Lung cancer (21)
Lymphoma (22)
Manufacturing (23)
MASH (4)
Medical device (406)
Medtech (406)
Mergers & acquisitions (623)
Metabolic disorders (34)
mRNA (5)
Multiple sclerosis (2)
NASH (1)
Neurodegenerative disease (4)
Neuropsychiatric disorders (2)
Neuroscience (85)
NextGen: Class of 2026 (78)
Non-profit (55)
Obesity (10)
Opinion (2)
Ovarian cancer (6)
Pain (3)
Pancreatic cancer (6)
Parkinson's disease (10)
Patents (10)
Patient recruitment (18)
People (984)
Pharmaceutical (1)
Phase 1 (383)
Phase 2 (797)
Phase 3 (858)
Pipeline (214)
Policy (1)
Postmarket research (87)
Preclinical (196)
Prostate cancer (12)
Radiopharmaceuticals (14)
Rare diseases (69)
Real estate (108)
Regulatory (594)
Reports (8)
Research institute (47)
Resumes & cover letters (1)
RSV (4)
Schizophrenia (18)
Series A (10)
Series B (12)
Sickle cell disease (5)
Spinal muscular atrophy (13)
Sponsored (1)
Startups (43)
Supply chain (1)
Vaccines (17)
Venture capital (3)
Weight loss (11)
Women's health (1)
Date
Today (3)
Last 7 days (15)
Last 30 days (55)
Last 365 days (722)
2026 (155)
2025 (964)
2024 (1096)
2023 (1024)
2022 (3216)
2021 (1389)
2020 (1166)
2019 (944)
2018 (703)
2017 (817)
2016 (777)
2015 (821)
2014 (662)
2013 (583)
2012 (594)
2011 (687)
2010 (618)
Location
Africa (18)
Arizona (4)
Asia (1163)
Australia (109)
California (229)
Canada (40)
China (15)
Colorado (2)
Connecticut (10)
Delaware (12)
Europe (6214)
Florida (37)
Georgia (4)
Illinois (14)
India (6)
Indiana (10)
Japan (15)
Kansas (2)
Louisiana (1)
Maine (2)
Maryland (11)
Massachusetts (187)
Michigan (4)
Montana (1)
Nevada (3)
New Hampshire (5)
New Jersey (108)
New York (54)
North Carolina (24)
Northern California (168)
Ohio (2)
Pennsylvania (27)
South America (29)
South Carolina (4)
Southern California (43)
Texas (39)
United States (803)
Utah (4)
Virginia (2)
Washington D.C. (1)
Washington State (14)
Wisconsin (1)
18,622 Results for "eurand milan italy".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy
June 19, 2025
·
9 min read
Press Releases
Alamar Biosciences Establishes European Headquarters and Distribution Center in Milan, Italy
July 30, 2024
·
2 min read
Pharm Country
SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 11th Advances Against Aspergillosis and Mucormycosis Conference, January 25 – 27, in Milan, Italy
SCYNEXIS, Inc. today announced the presentation of preclinical efficacy data on its second generation fungerp candidate SCY-247 for the treatment of mucormycosis at the 11th Advances Against Aspergillosis and Mucormycosis (AAAM) Conference in Milan, Italy from January 25 – 27, 2024.
January 5, 2024
·
4 min read
Press Releases
Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy
October 10, 2024
·
2 min read
Press Releases
Anaergia S.r.l. Expands Scope at Three Biomethane Facilities Being Built for QGM S.á.r.l. in Italy, Increasing Contracts by C$17 Million
March 17, 2026
·
3 min read
Press Releases
San Raffaele Hospital (Milan, Italy): new, promising results from the first patients implanted with the spinal neurostimulator. A new, high-frequency spinal stimulation protocol gives hope for motor recovery and reduced muscular spasticity
January 16, 2025
·
5 min read
Press Releases
Enlivex Appoints former Italy Prime Minister Matteo Renzi to Board of Directors
November 24, 2025
·
6 min read
Mapi Pharma to Present Plans for Additional Studies of GA Depot in Multiple Sclerosis and Other Indications and Highlight Latest Results on GA Depot in Relapsing MS at the ECTRIMS-ACTRIMS® Meeting in Milan, Italy October 11-13, 2023
Mapi Pharma Ltd. announced that recent clinical data from studies of GA Depot 40 mg will be presented at the forthcoming European Committee for Treatment and Research in Multiple Sclerosis & Americas Committee for Treatment and Research in Multiple Sclerosis meeting to take place in Milan, Italy, October 11 to 13.
October 10, 2023
·
4 min read
Business
Dr. Reddy’s Laboratories Announces the Appointment of Milan Kalawadia to CEO North America
Dr. Reddy’s Laboratories Ltd., announced the appointment of Milan Kalawadia as Chief Executive Officer, North America, and member of the Management Council.
May 28, 2024
·
5 min read
Press Releases
BetaGlue Therapeutics Expands its Clinical Trial in Italy after obtaining from the Italian Ministry of Health Approval to conduct its clinical study in Unresectable Locally Advanced Pancreatic Cancer (uLA-PDAC)
December 3, 2025
·
2 min read
1 of 1,863
Next
